GEHCGE HealthCare Technologies ...

Nasdaq


$ 81.11 $ -0.32 (-0.39 %)    

Wednesday, 08-May-2024 15:59:45 EDT
QQQ $ 440.26 $ -0.20 (-0.05 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 81.11
$ 81.18
$ 80.81 x 100
$ 81.15 x 100
$ 80.30 - $ 81.56
$ 62.30 - $ 94.47
2,723,776
na
36.82B
$ 1.27
$ 23.45
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-06-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 07-25-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-15-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-sunday-ge-healthcare-unviels-signa-magnus-head-only-magnetic-resonance-scanner-designed-to-explore-advancements-in-neuroscience-fda-510k-pending

SIGNA MAGNUSi is a high-performance head-only MR scanner from GE HealthCare that could expand the field of neuroscience, whic...

 last-weeks-worst-performing-stocks-are-these-15-large-cap-stocks-in-your-portfolio-april-28-may-4-2024

15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targ...

 b-of-a-securities-maintains-neutral-on-ge-healthcare-techs-lowers-price-target-to-86

B of A Securities analyst Craig Bijou maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target...

 mizuho-maintains-buy-on-ge-healthcare-techs-lowers-price-target-to-105

Mizuho analyst Anthony Petrone maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and lowers the price target from $110 ...

 stocks-dive-on-fears-of-hawkish-fed-treasury-yields-rise-bitcoin-tumbles-to-60000-whats-driving-markets-tuesday

Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the F...

 ge-healthcares-q1-earnings-miss-wall-street-projections-but--it-sticks-to-annual-guidance

GE Healthcare reports first-quarter sales of $4.6 billion, with net income of $374 million. Imaging and ultrasound segment reve...

 wall-street-on-edge-ahead-of-fed-decision-spotlight-falls-on-amazon-and-amd-earnings-analyst-says-stocks-survive-fragility-test-as-april-ends

U.S. stocks appear to be on the back foot early on Tuesday, with index futures trading modestly lower in early pre-market activ...

 ge-healthcare-techs-q1-2024-adj-eps-090-misses-091-estimate-sales-4650b-miss-4801b-estimate

GE HealthCare Techs (NASDAQ:GEHC) reported quarterly earnings of $0.90 per share which missed the analyst consensus estimate of...

 ge-healthcare-receives-fda-clearance-for-portrait-vsm-building-in-its-growing-ecosystem-of-connected-patient-monitoring-solutions

The portable vital signs monitor (VSM) adds to GE HealthCare's growing Portrait Ecosystem to help clinicians make timely tr...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 why-is-ge-aerospace-stock-trading-higher-today

Post-spin-off GE Aerospace (NYSE:GE) 

 elekta-and-ge-healthcares-mim-software-announced-collaboration-to-deliver-leading-cancer-treatment-planning-solutions

Elekta (EKTA-B.ST) and MIM Software Inc. (MIM), a leading provider of medical imaging management and artificial intelligence so...

 mizuho-maintains-buy-on-ge-healthcare-techs-raises-price-target-to-110

Mizuho analyst Anthony Petrone maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $96 t...

 evercore-isi-group-maintains-outperform-on-ge-healthcare-techs-raises-price-target-to-100

Evercore ISI Group analyst Vijay Kumar maintains GE HealthCare Techs (NASDAQ:GEHC) with a Outperform and raises the price ta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION